22 hasil

Increased antimicrobial resistance during the COVID-19 pandemic

Chih‐Cheng Lai; Shey‐Ying Chen; Wen‐Chien Ko dkk.

International Journal of Antimicrobial Agents · 2021 · Inggris · OpenAlex Scopus

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Philippe Colson; Jean‐Marc Rolain; Didier Raoult

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking

Ran Yu; Chen Liang; Rong Lan dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies

Ming Zhao

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

SARS-CoV-2 was already spreading in France in late December 2019

Antoine Deslandes; V. Berti; Yacine Tandjaoui-Lambotte dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status

Chih‐Cheng Lai; Cheng‐Yi Wang; Ya‐Hui Wang dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Wen‐Chien Ko; Jean‐Marc Rolain; Nan–Yao Lee dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Extra-respiratory manifestations of COVID-19

Chih‐Cheng Lai; Wen‐Chien Ko; Ping‐Ing Lee dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Procalcitonin levels in COVID-19 patients

Rui Hu; Chaofei Han; Shiyao Pei dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a pandemic. This study analysed 95 SARS-CoV-2-infected patients, including 62 moderate COVID-19 patients, 21 severe COVID-19 patients and 12 critical…

Coronavirus disease 2019 (COVID-19): current status and future perspectives

Heng Li; Shangming Liu; Xiao-Hua Yu dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Christian Albert Devaux; Jean‐Marc Rolain; Philippe Colson dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Recently, a novel coronavirus (2019-nCoV), officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Despite drastic containment measures, the spread of this virus is ongoing. SARS-CoV-2 is the aetiological agent of coronavirus disease 2019 (COVID-19)…

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

Lisheng Wang; Yiru Wang; Dawei Ye dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Chi Zhang; Zhao Wu; Jiawen Li dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

The epidemiology, diagnosis and treatment of COVID-19

Pan Zhai; Yanbing Ding; Xia Wu dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Philippe Colson; Jean‐Marc Rolain; Jean‐Christophe Lagier dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies

Atul Sharma; Swapnil Tiwari; Manas Kanti Deb dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection

Jacques Fantini; Coralie Di Scala; Henri Chahinian dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein

Naveen Vankadari

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine

Zahra Sahraei; Minoosh Shabani; Shervin Shokouhi dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus

Teicoplanin: an alternative drug for the treatment of COVID-19?

Sophie Alexandra Baron; Christian Albert Devaux; Philippe Colson dkk.

International Journal of Antimicrobial Agents · 2020 · Inggris · OpenAlex Scopus